Tfg Asset Management Gp LTD Precigen, Inc. Transaction History

Tfg Asset Management Gp LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.53 - $5.5 $88,525 - $137,929	-25,078 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$4.99 - $6.55 $730,815 - $959,286	-146,456 Reduced 85.38%	25,078 $125,000
Q2 2021 Aug 16, 2021	BUY	$6.24 - $8.22 $744,163 - $980,292	119,257 Added 228.13%	171,534 $1.12 Million
Q1 2021 May 17, 2021	BUY	$6.74 - $10.95 $352,346 - $572,433	52,277 New	52,277 $360,000
Q3 2020 Nov 13, 2020	SELL	$3.5 - $6.2 $65,219 - $115,530	-18,634 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$2.16 - $5.46 $54,000 - $136,500	-25,000 Reduced 57.29%	18,634 $93,000
Q1 2020 May 15, 2020	BUY	$1.46 - $7.19 $63,705 - $313,728	43,634 New	43,634 $148,000

148

162M

150K

29.5K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $408M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Tfg Asset Management Gp LTD, based on Form 13F filings with the SEC.

Stay updated on Tfg Asset Management Gp LTD with notifications on news.